Tilray is a diversified global consumer products company that operates across cannabis, beverages, pharmaceutical distribution, and wellness segments. In its cannabis business, Tilray cultivates and sells adult-use and medical products through a portfolio of brands. It maintains a leading position in the Canadian market and sells medical cannabis internationally in Europe, Australia, and Latin America. The beverage segment functions as a large craft brewing platform in the U.S. with brands like SweetWater and Montauk, alongside craft spirits from Breckenridge Distillery and a licensing agreement with Carlsberg. The acquisition of BrewDog established a global beverage presence with brewing and pub operations in the U.K. and Australia. Through Tilray Pharma, the company imports and distributes pharmaceutical product lines to pharmacies in Germany, which supports its medical cannabis distribution. The wellness segment focuses on hemp-based foods and energy drinks. Tilray utilizes various business models, including selling through provincial government channels in Canada, a three-tier wholesale system for U.S. beverages, and a pharmacy network in Germany. The company's growth strategy prioritizes expanding international cannabis reach and globalizing its beverage business. Tilray is positioning its beverage infrastructure and distribution capabilities to support cannabis-infused products in the U.S. should federal legalization occur.